US FDA News 3/3

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

US FDA approved BMS Sotyktu (deucravacitinib) for moderate to severe plaque psoriasis |iPharmaCenter

US FDA approved BMS Sotyktu (deucravacitinib) for moderate to severe plaque psoriasis |iPharmaCenter

ipharmaservices

Sep 11, 2022

0

bluebird bio's $2.8 million gene therapy Zynteglo received FDA nod for beta-thalassemia

bluebird bio's $2.8 million gene therapy Zynteglo received FDA nod for beta-thalassemia

ipharmaservices

Aug 19, 2022

0

BMS' Breyanzi was approved for relapsed or refractory LBCL | News | FDA | iPharmacenter

BMS' Breyanzi was approved for relapsed or refractory LBCL | News | FDA | iPharmacenter

ipharmaservices

Jun 25, 2022

0

FDA approved two Opdivo based regimens as a 1L treatment for ESCC | FDA News | iPharmaCenter

FDA approved two Opdivo based regimens as a 1L treatment for ESCC | FDA News | iPharmaCenter

ipharmaservices

May 30, 2022

0

FDA approved Kymriah for follicular lymphoma | Novartis | News | Cancer | | Updates | iPharmaCenter

FDA approved Kymriah for follicular lymphoma | Novartis | News | Cancer | | Updates | iPharmaCenter

ipharmaservices

May 29, 2022

0

FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

ipharmaservices

Dec 23, 2021

0

~$10 bn acquisition paying off for Novartis as FDA approved Novartis' Leqvio

~$10 bn acquisition paying off for Novartis as FDA approved Novartis' Leqvio

ipharmaservices

Dec 23, 2021

0

Gilead’s Trodelvy approved for triple-negative breast cancer in US

Gilead’s Trodelvy approved for triple-negative breast cancer in US

ipharmaservices

Apr 9, 2021

0

FDA to review the accelerated approvals of Keytruda, Opdivo, and Tecentriq

FDA to review the accelerated approvals of Keytruda, Opdivo, and Tecentriq

ipharmaservices

Mar 13, 2021

0

FDA approved Roche’s Gavreto for RET fusion-positive NSCLC

FDA approved Roche’s Gavreto for RET fusion-positive NSCLC

ipharmaservices

Sep 7, 2020

0

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page